Navigation Links
Healthcare Technologies Ltd. (NASDAQ: HCTL) Announces Extension of Letters of Intent to Acquire Majority Interest in Two Ethanol Plants
Date:1/15/2008

NEW YORK, January 15 /PRNewswire-FirstCall/ -- Healthcare Technologies Ltd., an Israeli corporation (the "Company") today announced the extension of the expiration dates to February 29, 2008 of two letters of intent to acquire majority control in two ethanol plants that are located in the Midwest for an aggregate purchase price of approximately $50 million in cash and ordinary shares. Each of the plants will have a name plate capacity of more 40 million gallons of ethanol. The closings of the acquisitions are subject to the completion of due diligence, the negotiation of definitive purchase documents and the receipt of financing.

On December 31, 2007, The Company completed a plan of arrangement in the nature of a reverse merger in which it acquired the principal assets of NexGen Biofuels Inc. in the field of ethanol and biodiesel fuel production, as well as NexGen's rights under the letters of intent. In consideration for such assets, which were valued at $58,000,0000, the Company issued Ordinary Shares at a price of $1.50 per share. Healthcare will continue the business of NexGen in the field of ethanol and biodiesel as a publicly traded company, and is in the process of changing its name to NexGen Biofuels Ltd.

SAFE HARBOR: This press release contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward looking statement made by or on behalf of Healthcare Technologies Ltd. Readers are referred to the documents filed by the company with the Securities and Exchange Commission, specifically the Form 8-K filed on January 7, 2008 that identifies important risks which could cause actual results to differ from those contained in the forward looking statements.

CONTACT: Eran Rotem CFO

+972-3-9277232/3


'/>"/>
SOURCE Healthcare Technologies Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
2. HealthCare Technologies Ltd. (NASDAQ: HCTL) Announces Receipt of NASDAQ Delisting Notice
3. Caliper Life Sciences to Present at JPMorgan 26th Annual Healthcare Conference Today
4. Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference
5. Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
6. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
7. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
8. Vical to Participate in Pandemic Influenza Panel at JPMorgan Healthcare Conference
9. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
10. ARCA Discovery, Inc. to Present at 26th Annual JPMorgan Healthcare Conference on January 8, 2008
11. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... NJ (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic ... one eye at a time. So which eye do you rinse first if a dangerous ... have Plum Duo Eye Wash with its unique dual eye piece. , “Whether ...
(Date:10/11/2017)... Oct. 11, 2017  VMS BioMarketing, a leading provider of ... oncology Clinical Nurse Educator (CNE) network, which will launch this ... communication among health care professionals to enhance the patient care ... staff, and other health care professionals to help women who ... ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):